CWM
EDIT icon

CIBC World Markets’s Editas Medicine EDIT Stock Holding History

CIBC World Markets’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$22.9K Sell
10,399
-7,991
-43% -$13.1K ﹤0.01% 1525
2025
Q1 		$21.3K Buy
+18,390
New +$27.1K ﹤0.01% 1792

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CIBC World Markets's EDIT Position: Q2 2025 in Review

CIBC World Markets reduced its Editas Medicine (EDIT) stake by 43% in Q2 2025, selling an estimated $13.1K and leaving 10,399 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

CIBC World Markets first reported a position in EDIT in Q1 2025 and has held it in 2 quarters since. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • CIBC World Markets held 10,399 shares of Editas Medicine worth $22.9K as of Q2 2025.
  • CIBC World Markets sold 7,991 Editas Medicine shares in Q2 2025, an estimated $13.1K.
  • Editas Medicine made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1525 holding.
  • CIBC World Markets first reported a position in Editas Medicine in Q1 2025 and has held it in 2 quarters since.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.